Deutsche Bank’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.99M Sell
170,454
-447,721
-72% -$5.22M ﹤0.01% 1705
2025
Q1
$4.59M Sell
618,175
-12,402
-2% -$92.1K ﹤0.01% 1279
2024
Q4
$3.78M Buy
630,577
+503,842
+398% +$3.02M ﹤0.01% 1468
2024
Q3
$649K Sell
126,735
-458,968
-78% -$2.35M ﹤0.01% 2282
2024
Q2
$2.12M Sell
585,703
-18,803
-3% -$68.1K ﹤0.01% 1588
2024
Q1
$1.94M Buy
604,506
+1,450
+0.2% +$4.66K ﹤0.01% 1654
2023
Q4
$2.95M Buy
603,056
+546,069
+958% +$2.68M ﹤0.01% 1469
2023
Q3
$311K Sell
56,987
-540,190
-90% -$2.94M ﹤0.01% 2466
2023
Q2
$4.01M Sell
597,177
-37,886
-6% -$254K ﹤0.01% 1322
2023
Q1
$5.61M Buy
635,063
+12,345
+2% +$109K ﹤0.01% 1196
2022
Q4
$4.76M Sell
622,718
-31,335
-5% -$239K ﹤0.01% 1234
2022
Q3
$4.66M Buy
654,053
+5,651
+0.9% +$40.2K ﹤0.01% 1239
2022
Q2
$5.25M Buy
648,402
+306,982
+90% +$2.48M ﹤0.01% 1256
2022
Q1
$4.74M Buy
341,420
+206,421
+153% +$2.87M ﹤0.01% 1447
2021
Q4
$3.79M Sell
134,999
-22,012
-14% -$618K ﹤0.01% 1600
2021
Q3
$5.34M Buy
157,011
+10,922
+7% +$371K ﹤0.01% 1465
2021
Q2
$5.97M Sell
146,089
-18,711
-11% -$765K ﹤0.01% 1414
2021
Q1
$6.64M Buy
164,800
+125,067
+315% +$5.04M ﹤0.01% 1395
2020
Q4
$2.35M Sell
39,733
-113,601
-74% -$6.72M ﹤0.01% 1823
2020
Q3
$7.46M Buy
153,334
+107,309
+233% +$5.22M 0.01% 1082
2020
Q2
$2.23M Sell
46,025
-359,678
-89% -$17.4M ﹤0.01% 1727
2020
Q1
$11.3M Buy
405,703
+384,326
+1,798% +$10.7M 0.01% 871
2019
Q4
$637K Buy
21,377
+13,750
+180% +$410K ﹤0.01% 2594
2019
Q3
$235K Buy
+7,627
New +$235K ﹤0.01% 3056